Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Stemline Therapeutics Inc (NASDAQ:STML)

10.90
Delayed Data
As of Oct 18
 -0.20 / -1.80%
Today’s Change
5.50
Today|||52-Week Range
14.60
+1.87%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.00654.2K1.0M
 
 
 
Depreciation And Amortization76.7K153.3K153.8K80.3K
 
 
 
 
 
 
Operating ExpensesGross Income-76.7K-153.3K----
 
 
 
General Expenses24.0M29.2M38.1M39.8M
 
 
 
 
 
Research And Development16.2M21.2M29.5M27.9M
 
 
 
 
 
Total Operating Expenses24.1M29.3M38.3M39.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-24.1M-29.3M-37.6M-38.9M
 
 
 
 
 
Extraordinary Credit30.4K0.000.000.00
 
 
Interest Expense On Debt516.9K0.000.000.00
 
 
Other Expenses321.3K338.9K1.6K11.4K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-24.2M-28.8M-37.2M-38.3M
 
 
 
 
 
Income Taxes0.000.000.00-25.3K
 
 
Net Income-24.2M-28.8M-37.2M-38.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS10.3M12.9M17.3M17.8M
 
 
 
 
 
Shares To Calculate EPS Diluted10.3M12.9M17.3M17.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.35-$2.23-$2.15-$2.15
 
 
 
 
 
EPS Diluted-$2.35-$2.23-$2.15-$2.15